Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / BIOTECH ETF
-
Number of holders
-
121
-
Total 13F shares, excl. options
-
901K
-
Shares change
-
+95.6K
-
Total reported value, excl. options
-
$170M
-
Value change
-
+$17.8M
-
Put/Call ratio
-
3.12
-
Number of buys
-
40
-
Number of sells
-
-44
-
Price
-
$189.33
Significant Holders of VANECK ETF TRUST - BIOTECH ETF (BBH) as of Q4 2021
137 filings reported holding BBH - VANECK ETF TRUST - BIOTECH ETF as of Q4 2021.
VANECK ETF TRUST - BIOTECH ETF (BBH) has 121 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 901K shares
.
Largest 10 shareholders include GOLDMAN SACHS GROUP INC (124K shares), BANK OF AMERICA CORP /DE/ (121K shares), MORGAN STANLEY (88.6K shares), UBS Group AG (40.5K shares), LPL Financial LLC (39K shares), ROYAL BANK OF CANADA (37.9K shares), MOGY JOEL R INVESTMENT COUNSEL INC (33.7K shares), MURPHY CAPITAL MANAGEMENT INC (32.5K shares), Kestra Advisory Services, LLC (24.4K shares), and COMMONWEALTH EQUITY SERVICES, LLC (17.5K shares).
This table shows the top 121 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.